Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

[Abnormal methylation patterns of SFRP1 gene in cells of leukemia and inhibition of arsenic trioxide on the SFRP1 gene].

Wang Y, Zhu XX, Zhu CS.

Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):157-9. Chinese. No abstract available.

PMID:
23611225
2.

[p15 gene expression in acute lymphoblastic leukemia cell line Molt4 induced by arsenic trioxide].

Jin H, Lou F, Yu L.

Zhonghua Xue Ye Xue Za Zhi. 2001 Jan;22(1):24-6. Chinese.

PMID:
11877046
3.

[Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].

Fang HL, Yu ZC, Zhu HB, Jin YT.

Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):658-63. doi: 10.3760/cma.j.issn.0253-3766.2012.09.004. Chinese.

PMID:
23159077
4.

[Induced RAS association domain family gene 1A gene expression by arsenic trioxide in nasopharyngeal carcinoma cell].

Hu JL, Zhang YF, Qiu ZD, Liang HH.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Oct;44(10):866-70. Chinese.

PMID:
20079060
5.

Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.

Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW.

Cancer. 2006 Aug 1;107(3):579-90.

6.

Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.

Du J, Zhou N, Liu H, Jiang F, Wang Y, Hu C, Qi H, Zhong C, Wang X, Li Z.

PLoS One. 2012;7(4):e35957. doi: 10.1371/journal.pone.0035957. Epub 2012 Apr 27.

7.
8.

[Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].

Ye XS, Liu T, Cui X, Meng WT, Xi YM.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Jan;38(1):57-9. Chinese.

PMID:
17294728
9.

Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines.

Peng CY, Jiang J, Zheng HT, Liu XS.

Leuk Lymphoma. 2010 Feb;51(2):297-303. doi: 10.3109/10428190903486212.

PMID:
20038232
10.
11.

[Effects of arsenic trioxide on Id4 methylation status in bone marrow mononuclear cells and its clinical efficacy for myelodysplastic syndrome].

Shao X, Lu R, Guan X, Liu J, Zhao J, Shao Z, Zhan Z, Ma J.

Zhonghua Xue Ye Xue Za Zhi. 2014 Mar;35(3):247-50. doi: 10.3760/cma.j.issn.0253-2727.2014.03.017. Chinese. No abstract available.

PMID:
24666496
12.

sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia.

Pehlivan M, Sercan Z, Sercan HO.

Leuk Res. 2009 Aug;33(8):1062-7. doi: 10.1016/j.leukres.2008.11.013. Epub 2008 Dec 31.

PMID:
19118898
13.

Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia.

Uhm KO, Lee ES, Lee YM, Park JS, Kim SJ, Kim BS, Kim HS, Park SH.

J Korean Med Sci. 2009 Jun;24(3):493-7. doi: 10.3346/jkms.2009.24.3.493. Epub 2009 Jun 18.

14.
15.

Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.

Chen GQ, Zhou L, Styblo M, Walton F, Jing Y, Weinberg R, Chen Z, Waxman S.

Cancer Res. 2003 Apr 15;63(8):1853-9.

16.

SFRP1 promoter methylation and expression in human trabecular meshwork cells.

Mao W, Rubin JS, Anoruo N, Wordinger RJ, Clark AF.

Exp Eye Res. 2012 Apr;97(1):130-6. doi: 10.1016/j.exer.2012.01.003. Epub 2012 Jan 9.

PMID:
22248913
18.

[Arsenic trioxide induced p15INK4B gene expression in myelodysplastic syndrome cell line MUTZ-1].

Tong H, Lin M.

Zhonghua Xue Ye Xue Za Zhi. 2002 Dec;23(12):638-41. Chinese.

PMID:
12667347
19.

Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.

Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG.

Oncogene. 2007 Aug 16;26(38):5680-91. Epub 2007 Mar 12.

PMID:
17353908
20.

Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.

Takada T, Yagi Y, Maekita T, Imura M, Nakagawa S, Tsao SW, Miyamoto K, Yoshino O, Yasugi T, Taketani Y, Ushijima T.

Cancer Sci. 2004 Sep;95(9):741-4.

Supplemental Content

Support Center